PuSH - Publication Server of Helmholtz Zentrum München

Halama, A. ; Riesen, N. ; Hrabě de Angelis, M. ; Adamski, J.

Identification of biomarkers for apoptosis in cancer cell lines using metabolomics: Tolls for individualized medicine.

J. Intern. Med. 274, 425-439 (2013)
DOI PMC
Open Access Green as soon as Postprint is submitted to ZB.
BACKGROUND: Metabolomics is a versatile unbiased method to search for biomarkers of human disease. In particular, one approach in cancer therapy is to promote apoptosis in tumour cells; this could be improved with specific biomarkers of apoptosis for monitoring treatment. We recently observed specific metabolic patterns in apoptotic cell lines; however, in that study, apoptosis was only induced with one pro-apoptotic agent, staurosporine. OBJECTIVE: The aim of this study was to find novel biomarkers of apoptosis by verifying our previous findings using two further pro-apoptotic agents, 5-fluorouracil and etoposide, that are commonly used in anticancer treatment. METHODS: Metabolic parameters were assessed in HepG2 and HEK293 cells using the newborn screening assay adapted for cell culture approaches, quantifying the levels of amino acids and acylcarnitines with mass spectrometry. RESULTS: We were able to identify apoptosis-specific changes in the metabolite profile. Moreover, the amino acids alanine and glutamate were both significantly up-regulated in apoptotic HepG2 and HEK293 cells irrespective of the apoptosis inducer. CONCLUSION: Our observations clearly indicate the potential of metabolomics in detecting metabolic biomarkers applicable in theranostics and for monitoring drug efficacy.
Altmetric
Additional Metrics?
[➜Log in]
Edit extra informations Login
Publication type Article: Journal article
Document type Review
Corresponding Author
Keywords Apoptosis; Biomarkers; Cancer; Mass spectronomy; Metabolomics; Human Colorectal-cancer; Acute Myeloid-leukemia; Targeted Metabolomics; Prostate-cancer; Breast-cancer; Alzheimers-disease; Mass-spectrometry; Tumor Progression; Systems Biology; Lung-cancer
ISSN (print) / ISBN 0954-6820
e-ISSN 1365-2796
Journal Journal of Internal Medicine
Quellenangaben Volume: 274, Issue: 5, Pages: 425-439 Article Number: , Supplement: ,
Publisher Wiley
Publishing Place Hoboken
Non-patent literature Publications
Reviewing status Peer reviewed
Institute(s) Molekulare Endokrinologie und Metabolismus (MEM)
Institute of Experimental Genetics (IEG)